Briefing
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial.
Sensitivity 91.37%, specificity 95.09%.
- n: Development 382; prospective validation 947 (ChiCTR2300076543)
- Assay: FGFR3 and TERT mutations plus ONECUT2 and VIM methylation